Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial.
Identifieur interne : 003A19 ( Main/Exploration ); précédent : 003A18; suivant : 003A20Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial.
Auteurs : Paul Welsh [Royaume-Uni] ; Mark Woodward [Australie] ; Graham S. Hillis [Australie] ; Qiang Li [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Neil Poulter [Royaume-Uni] ; Louise Ryan [Australie] ; Stephen Harrap [Australie] ; Ansuhka Patel [Australie] ; John Chalmers [Australie] ; Naveed Sattar [Royaume-Uni]Source :
- Diabetes care [ 1935-5548 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Diabète de type 2 (), Diabète de type 2 (sang), Facteurs de risque, Femelle, Fragments peptidiques (sang), Humains, Incidence, Maladies du rein (sang), Maladies du rein (étiologie), Marqueurs biologiques (sang), Mâle, Peptide natriurétique cérébral (sang), Pronostic, Troponine (sang), Études cas-témoins, Études de cohortes, Évaluation des risques.
- MESH :
- sang : Diabète de type 2, Fragments peptidiques, Maladies du rein, Marqueurs biologiques, Peptide natriurétique cérébral, Troponine.
- étiologie : Maladies du rein.
- Adulte d'âge moyen, Diabète de type 2, Facteurs de risque, Femelle, Humains, Incidence, Mâle, Pronostic, Études cas-témoins, Études de cohortes, Évaluation des risques.
English descriptors
- KwdEn :
- Biomarkers (blood), Case-Control Studies, Cohort Studies, Diabetes Mellitus, Type 2 (blood), Diabetes Mellitus, Type 2 (complications), Female, Humans, Incidence, Kidney Diseases (blood), Kidney Diseases (etiology), Male, Middle Aged, Natriuretic Peptide, Brain (blood), Peptide Fragments (blood), Prognosis, Risk Assessment, Risk Factors, Troponin (blood).
- MESH :
- chemical , blood : Biomarkers, Natriuretic Peptide, Brain, Peptide Fragments, Troponin.
- blood : Diabetes Mellitus, Type 2, Kidney Diseases.
- complications : Diabetes Mellitus, Type 2.
- etiology : Kidney Diseases.
- Case-Control Studies, Cohort Studies, Female, Humans, Incidence, Male, Middle Aged, Prognosis, Risk Assessment, Risk Factors.
Abstract
We investigated microvascular event risk in people with type 2 diabetes and assessed whether N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity troponin T (hsTnT) improved prediction.
DOI: 10.2337/dc13-2625
PubMed: 24879844
Affiliations:
- Australie, France, Royaume-Uni
- Angleterre, Grand Londres, Nouvelle-Galles du Sud, Victoria (État), Écosse, Île-de-France
- Glasgow, Londres, Melbourne, Paris, Sydney
- University College de Londres, Université de Glasgow, Université de Sydney
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003588
- to stream PubMed, to step Curation: 003475
- to stream PubMed, to step Checkpoint: 003475
- to stream Ncbi, to step Merge: 001A76
- to stream Ncbi, to step Curation: 001A76
- to stream Ncbi, to step Checkpoint: 001A76
- to stream Main, to step Merge: 003A62
- to stream Main, to step Curation: 003A19
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial.</title><author><name sortKey="Welsh, Paul" sort="Welsh, Paul" uniqKey="Welsh P" first="Paul" last="Welsh">Paul Welsh</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow</wicri:regionArea><orgName type="university">Université de Glasgow</orgName><placeName><settlement type="city">Glasgow</settlement><region type="country">Écosse</region></placeName></affiliation></author><author><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name><affiliation wicri:level="4"><nlm:affiliation>George Institute for Global Health, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Hillis, Graham S" sort="Hillis, Graham S" uniqKey="Hillis G" first="Graham S" last="Hillis">Graham S. Hillis</name><affiliation wicri:level="4"><nlm:affiliation>George Institute for Global Health, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Li, Qiang" sort="Li, Qiang" uniqKey="Li Q" first="Qiang" last="Li">Qiang Li</name><affiliation wicri:level="4"><nlm:affiliation>George Institute for Global Health, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name><affiliation wicri:level="3"><nlm:affiliation>Service d'Endocrinologie Diabétologie Nutrition, Groupe Hospitalier Bichat-Claude Bernard, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service d'Endocrinologie Diabétologie Nutrition, Groupe Hospitalier Bichat-Claude Bernard, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Williams, Bryan" sort="Williams, Bryan" uniqKey="Williams B" first="Bryan" last="Williams">Bryan Williams</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Cardiovascular Sciences, University College London, and the National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, U.K.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Cardiovascular Sciences, University College London, and the National Institute for Health Research University College London Hospitals Biomedical Research Centre, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Poulter, Neil" sort="Poulter, Neil" uniqKey="Poulter N" first="Neil" last="Poulter">Neil Poulter</name><affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Pharmacology, Imperial College London, London, U.K.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Clinical Pharmacology, Imperial College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Ryan, Louise" sort="Ryan, Louise" uniqKey="Ryan L" first="Louise" last="Ryan">Louise Ryan</name><affiliation wicri:level="3"><nlm:affiliation>School of Mathematical Sciences, University of Technology, Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>School of Mathematical Sciences, University of Technology, Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Harrap, Stephen" sort="Harrap, Stephen" uniqKey="Harrap S" first="Stephen" last="Harrap">Stephen Harrap</name><affiliation wicri:level="3"><nlm:affiliation>University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Melbourne and Royal Melbourne Hospital, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Patel, Ansuhka" sort="Patel, Ansuhka" uniqKey="Patel A" first="Ansuhka" last="Patel">Ansuhka Patel</name><affiliation wicri:level="4"><nlm:affiliation>George Institute for Global Health, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><affiliation wicri:level="4"><nlm:affiliation>George Institute for Global Health, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Sattar, Naveed" sort="Sattar, Naveed" uniqKey="Sattar N" first="Naveed" last="Sattar">Naveed Sattar</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K. naveed.sattar@glasgow.ac.uk.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow</wicri:regionArea><orgName type="university">Université de Glasgow</orgName><placeName><settlement type="city">Glasgow</settlement><region type="country">Écosse</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24879844</idno><idno type="pmid">24879844</idno><idno type="doi">10.2337/dc13-2625</idno><idno type="wicri:Area/PubMed/Corpus">003588</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003588</idno><idno type="wicri:Area/PubMed/Curation">003475</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003475</idno><idno type="wicri:Area/PubMed/Checkpoint">003475</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003475</idno><idno type="wicri:Area/Ncbi/Merge">001A76</idno><idno type="wicri:Area/Ncbi/Curation">001A76</idno><idno type="wicri:Area/Ncbi/Checkpoint">001A76</idno><idno type="wicri:Area/Main/Merge">003A62</idno><idno type="wicri:Area/Main/Curation">003A19</idno><idno type="wicri:Area/Main/Exploration">003A19</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial.</title><author><name sortKey="Welsh, Paul" sort="Welsh, Paul" uniqKey="Welsh P" first="Paul" last="Welsh">Paul Welsh</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow</wicri:regionArea><orgName type="university">Université de Glasgow</orgName><placeName><settlement type="city">Glasgow</settlement><region type="country">Écosse</region></placeName></affiliation></author><author><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name><affiliation wicri:level="4"><nlm:affiliation>George Institute for Global Health, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Hillis, Graham S" sort="Hillis, Graham S" uniqKey="Hillis G" first="Graham S" last="Hillis">Graham S. Hillis</name><affiliation wicri:level="4"><nlm:affiliation>George Institute for Global Health, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Li, Qiang" sort="Li, Qiang" uniqKey="Li Q" first="Qiang" last="Li">Qiang Li</name><affiliation wicri:level="4"><nlm:affiliation>George Institute for Global Health, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name><affiliation wicri:level="3"><nlm:affiliation>Service d'Endocrinologie Diabétologie Nutrition, Groupe Hospitalier Bichat-Claude Bernard, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service d'Endocrinologie Diabétologie Nutrition, Groupe Hospitalier Bichat-Claude Bernard, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Williams, Bryan" sort="Williams, Bryan" uniqKey="Williams B" first="Bryan" last="Williams">Bryan Williams</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Cardiovascular Sciences, University College London, and the National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, U.K.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Cardiovascular Sciences, University College London, and the National Institute for Health Research University College London Hospitals Biomedical Research Centre, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Poulter, Neil" sort="Poulter, Neil" uniqKey="Poulter N" first="Neil" last="Poulter">Neil Poulter</name><affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Pharmacology, Imperial College London, London, U.K.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Clinical Pharmacology, Imperial College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Ryan, Louise" sort="Ryan, Louise" uniqKey="Ryan L" first="Louise" last="Ryan">Louise Ryan</name><affiliation wicri:level="3"><nlm:affiliation>School of Mathematical Sciences, University of Technology, Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>School of Mathematical Sciences, University of Technology, Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Harrap, Stephen" sort="Harrap, Stephen" uniqKey="Harrap S" first="Stephen" last="Harrap">Stephen Harrap</name><affiliation wicri:level="3"><nlm:affiliation>University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Melbourne and Royal Melbourne Hospital, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Patel, Ansuhka" sort="Patel, Ansuhka" uniqKey="Patel A" first="Ansuhka" last="Patel">Ansuhka Patel</name><affiliation wicri:level="4"><nlm:affiliation>George Institute for Global Health, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><affiliation wicri:level="4"><nlm:affiliation>George Institute for Global Health, University of Sydney, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>George Institute for Global Health, University of Sydney, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Sattar, Naveed" sort="Sattar, Naveed" uniqKey="Sattar N" first="Naveed" last="Sattar">Naveed Sattar</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K. naveed.sattar@glasgow.ac.uk.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow</wicri:regionArea><orgName type="university">Université de Glasgow</orgName><placeName><settlement type="city">Glasgow</settlement><region type="country">Écosse</region></placeName></affiliation></author></analytic><series><title level="j">Diabetes care</title><idno type="eISSN">1935-5548</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biomarkers (blood)</term><term>Case-Control Studies</term><term>Cohort Studies</term><term>Diabetes Mellitus, Type 2 (blood)</term><term>Diabetes Mellitus, Type 2 (complications)</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Kidney Diseases (blood)</term><term>Kidney Diseases (etiology)</term><term>Male</term><term>Middle Aged</term><term>Natriuretic Peptide, Brain (blood)</term><term>Peptide Fragments (blood)</term><term>Prognosis</term><term>Risk Assessment</term><term>Risk Factors</term><term>Troponin (blood)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Diabète de type 2 ()</term><term>Diabète de type 2 (sang)</term><term>Facteurs de risque</term><term>Femelle</term><term>Fragments peptidiques (sang)</term><term>Humains</term><term>Incidence</term><term>Maladies du rein (sang)</term><term>Maladies du rein (étiologie)</term><term>Marqueurs biologiques (sang)</term><term>Mâle</term><term>Peptide natriurétique cérébral (sang)</term><term>Pronostic</term><term>Troponine (sang)</term><term>Études cas-témoins</term><term>Études de cohortes</term><term>Évaluation des risques</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Biomarkers</term><term>Natriuretic Peptide, Brain</term><term>Peptide Fragments</term><term>Troponin</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Diabetes Mellitus, Type 2</term><term>Kidney Diseases</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Diabetes Mellitus, Type 2</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Kidney Diseases</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Diabète de type 2</term><term>Fragments peptidiques</term><term>Maladies du rein</term><term>Marqueurs biologiques</term><term>Peptide natriurétique cérébral</term><term>Troponine</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Maladies du rein</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Case-Control Studies</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Prognosis</term><term>Risk Assessment</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Diabète de type 2</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Mâle</term><term>Pronostic</term><term>Études cas-témoins</term><term>Études de cohortes</term><term>Évaluation des risques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We investigated microvascular event risk in people with type 2 diabetes and assessed whether N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity troponin T (hsTnT) improved prediction.</div></front></TEI><affiliations><list><country><li>Australie</li><li>France</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li><li>Nouvelle-Galles du Sud</li><li>Victoria (État)</li><li>Écosse</li><li>Île-de-France</li></region><settlement><li>Glasgow</li><li>Londres</li><li>Melbourne</li><li>Paris</li><li>Sydney</li></settlement><orgName><li>University College de Londres</li><li>Université de Glasgow</li><li>Université de Sydney</li></orgName></list><tree><country name="Royaume-Uni"><region name="Écosse"><name sortKey="Welsh, Paul" sort="Welsh, Paul" uniqKey="Welsh P" first="Paul" last="Welsh">Paul Welsh</name></region><name sortKey="Poulter, Neil" sort="Poulter, Neil" uniqKey="Poulter N" first="Neil" last="Poulter">Neil Poulter</name><name sortKey="Sattar, Naveed" sort="Sattar, Naveed" uniqKey="Sattar N" first="Naveed" last="Sattar">Naveed Sattar</name><name sortKey="Williams, Bryan" sort="Williams, Bryan" uniqKey="Williams B" first="Bryan" last="Williams">Bryan Williams</name></country><country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name></region><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><name sortKey="Harrap, Stephen" sort="Harrap, Stephen" uniqKey="Harrap S" first="Stephen" last="Harrap">Stephen Harrap</name><name sortKey="Hillis, Graham S" sort="Hillis, Graham S" uniqKey="Hillis G" first="Graham S" last="Hillis">Graham S. Hillis</name><name sortKey="Li, Qiang" sort="Li, Qiang" uniqKey="Li Q" first="Qiang" last="Li">Qiang Li</name><name sortKey="Patel, Ansuhka" sort="Patel, Ansuhka" uniqKey="Patel A" first="Ansuhka" last="Patel">Ansuhka Patel</name><name sortKey="Ryan, Louise" sort="Ryan, Louise" uniqKey="Ryan L" first="Louise" last="Ryan">Louise Ryan</name></country><country name="France"><region name="Île-de-France"><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A19 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003A19 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24879844
|texte= Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24879844" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |